🇺🇸 FDA

Intelligence Platform

Patents

Browse 132 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8058403

Antibodies to stromal cell-derived factor-1 polypeptides

Five Prime Therapeutics, Inc. · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7982014

FGFR3-IIIc fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846892

Compositions and methods for Alzheimer's disease

Primex Clinical Laboratories, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776564

Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and method

Five Prime Therapeutics, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678890

Compositions and methods of treating disease with FGFR fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7621740

Mahonia aquifolium extract, extraction process and pharmaceutical composition containing t

Prime Pharmaceutical Corporation · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618616

Skin-protective compositions effective against vesicants and percutaneous chemical agents

State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572764

Uses of chemically-modified cholinesterases for detoxification of organophosporus compound

State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7205006

Mahonia aquifolium extract, extraction process and pharmaceutical composition containing t

Prime Pharmaceutical Corporation · Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6380167

Methods for anti-tumor therapy

PrimeCyte, Inc. · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6355790

Inhibition of HIV replication using a mutated transfer RNA primer

The Regents of the University of California · Granted Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6274751

Wax esters enriched in .omega.-3 unsaturated fatty acids, their preparation and their use

PRIME EUROPEAN THERAPEUTICALS S.P.A. · Granted Tue Aug 14 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired